Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management

References

• Lewis DA. The gonococcus fights back – is this time a knock out? Sex. Transm. Infect.86(6), 415–421 (2010).
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro. Surveill.15(47), pii: 19721 (2010).
   Google Scholar
• Ison C, Hussey J, Sankar K, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro. Surveill.16(14), pii: 19833 (2011).
   Google Scholar
• Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro. Surveill.16(6), pii: 19792 (2011).
   Google Scholar
• Ito M, Deguchi T, Mizutani KS et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob. Agents Chemother.49(1), 137–143 (2005).
   PubMed Web of Science ®Google Scholar
• Ameyama S, Onodera S, Takahata M et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob. Agents Chemother.46(12), 3744–3749 (2002).
   PubMed Web of Science ®Google Scholar
• Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J. Antimicrob. Chemother.62(3), 490–494 (2008).
   PubMed Web of Science ®Google Scholar
• Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J. Antimicrob. Chemother.64(2), 353–358 (2009).
   PubMed Web of Science ®Google Scholar
• Starnino S, Stefanelli P; Neisseria gonorrhoeae Italian Study Group. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother.63(6), 1200–1204 (2009).
   PubMed Web of Science ®Google Scholar
• Galarza PG, Alcalá B, Salcedo C et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex. Transm. Infect.36(12), 787–788 (2009).
   Google Scholar
• Galarza PG, Abad R, Canigia LF et al. New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother.54(4), 1652–1653 (2010).
   PubMedGoogle Scholar
• Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob. Agents Chemother.54(9), 3812–3816 (2010).
   PubMed Web of Science ®Google Scholar
• Forsyth A, Moyes A, Young H. Increased ciprofloxacin resistance in gonococci isolated in Scotland. Lancet356(9246), 1984–1985 (2000).
   PubMedGoogle Scholar
• Fenton KA, Ison C, Johnson AP et al. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet361(9372), 1867–1869 (2003).
   PubMedGoogle Scholar
• Cole MJ, Chisholm SA, Hoffmann S, Stary A, Lowndes CM, Ison CA; European Surveillance of Sexually Transmitted Infections Network. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex. Transm. Infect.86(6), 427–432 (2010).
   PubMed Web of Science ®Google Scholar
• Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales (GRASP): report of 2009 data. Health Protection Report Vol. 4, No. 34 (2010).
   Google Scholar
• Centre for Disease Control and Prevention. Antibiotic-resistant strains of Neisseria gonorrhoeae: policy guidelines for detection, management and control. MMWR36(Suppl. 5S), 13S (1987).
   PubMedGoogle Scholar
• WHO. Guidelines for the Management of Sexually Transmitted Diseases. WHO, Geneva, Switzerland (2003).
   Google Scholar
• Eastick K. Gonococcal antibiotic surveillance in Scotland (GASS): prevalence, patterns and trends in 2009. HPS Weekly Report25(44), 339–342 (2010).
   Google Scholar
• Bindayna KM, Ison CA. Sampling methods for monitoring changes in gonococcal populations. Epidemiol. Infect.103(1), 203–209 (1989).
   PubMedGoogle Scholar
• Lewis DA, Ison CA, Forster GE, Goh BT. Tetracycline-resistant Neisseria gonorrhoeae. Characteristics of patients and isolates at a London Genitourinary Medicine Clinic. Sex. Transm. Infect.23(5), 378–383 (1996).
   Google Scholar
• Ivens D, Martin I, Ison C. Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy? Int. J. STD AIDS11(12), 774–776 (2000).
   PubMedGoogle Scholar
• Turner A, Jephcott AE, Haji TC, Gupta PC. Ciprofloxacin resistant Neisseria gonorrhoeae in the UK. Genitourin. Med.66(1), 43 (1990).
   PubMedGoogle Scholar
• Turner A, Gough KR, Jephcott AE, McLean AN. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin. Med.71(4), 265–266 (1995).
   PubMedGoogle Scholar
• Ison CA, Martin IM. Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group. Sex. Transm. Infect.75(2), 107–111 (1999).
   PubMedGoogle Scholar
• Ison CA, Martin IM; London Gonococcal Working Group. Gonorrhoea in London: usefulness of first line therapies. Sex. Transm. Infect.78(2), 106–109 (2002).
   PubMedGoogle Scholar
• Paine TC, Fenton KA, Herring A et al. GRASP: a new national sentinel surveillance initiative for monitoring gonococcal antimicrobial resistance in England and Wales. Sex. Transm. Infect.77(6), 398–401 (2001).
   PubMedGoogle Scholar
• Hughes G, Nichols T, Ison CA. Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales. Sex. Transm. Infect. (2011) (In Press).
   Google Scholar
• Ison CA, Woodford PJ, Madders H, Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob. Agents Chemother.42(11), 2919–2922 (1998).
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters (version 1.3). 5 January 2011.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S20. CLSI, PA, USA (2010).
   Google Scholar
• Andrews JM; BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J. Antimicrob. Chemother.64(3), 454–489 (2009).
   PubMed Web of Science ®Google Scholar
• Bignell CJ. BASHH guideline for gonorrhoea. Sex. Transm. Infect.80(5), 330–331 (2004).
   PubMedGoogle Scholar
• Palmer HM, Young H, Martin IM, Ison CA, Spratt BG. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis. Sex. Transm. Infect.81(5), 403–407 (2005).
   PubMedGoogle Scholar
• Palmer HM, Young H. Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men. Int. J. STD AIDS17(4), 254–256 (2006).
   PubMedGoogle Scholar
• Hughes G, Simms I, Leong G. Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sex. Transm. Infect.83(6), 433–435 (2007).
   PubMedGoogle Scholar
• Rise in new diagnoses of sexually transmitted infections (UK, 2009). Health Protection Report Vol 4, No. 34 (2010).
   Google Scholar
• Delpech V, Martin IM, Hughes G et al. Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001–2006. Sex. Transm. Infect.85(5), 317–321 (2009).
   PubMed Web of Science ®Google Scholar
• Young H, McElhinney J, Palmer HM; Scottish gonococcal surveillance contributors. Extended surveillance of gonorrhoea in Scotland 2003. Int. J. STD AIDS17(10), 687–692 (2006).
   PubMedGoogle Scholar
• O’Rourke M, Ison CA, Renton AM, Spratt AM. Opa-typing: a high-resolution tool for studying the epidemiology of gonorrhoea. Mol. Microbiol.17(5), 865–875 (1995).
   PubMedGoogle Scholar
• Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis.189(8), 1497–1505 (2004).
   PubMedGoogle Scholar
• Palmer HM, Leeming JP, Turner A. Investigation of an outbreak of ciprofloxacin-resistant Neisseria gonorrhoeae using a simplified opa-typing method. Epidemiol. Infect.126(2), 219–224 (2001).
   PubMedGoogle Scholar
• Palmer HM, Young H, Martin IM, Ison CA, Spratt BG. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis. Sex. Transm. Infect.81(5), 403–407 (2005).
   PubMedGoogle Scholar
• Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J. Infect. Dis.192(7), 1191–1195 (2005).
   PubMedGoogle Scholar
• Moodley P, Martin IM, Pillay K, Ison CA, Sturm AW. Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa. Sex. Transm. Infect.33(6), 357–360 (2006).
   Google Scholar
• Monfort L, Caro V, Devaux Z, Delannoy AS, Brisse S, Sednaoui P. First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone. J. Clin. Microbiol.47(11), 3540–3545 (2009).
   PubMedGoogle Scholar
• Starnino S, Suligoi B, Regine V et al. Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. Clin. Microbiol. Infect.14(10), 949–954 (2008).
   PubMedGoogle Scholar
• Florindo C, Pereira R, Boura M et al. Genotypes and antimicrobial-resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004–2009). Sex. Transm. Infect.86(6), 449–453 (2010).
   PubMedGoogle Scholar
• Wong WW, Huang CT, Li LH, Chiang CC, Chen BD, Li SY. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J. Clin. Microbiol.46(12), 3931–3934 (2008).
   PubMed Web of Science ®Google Scholar
• Morris AK, Palmer HM, Young H. Opa-typing can identify epidemiologically distinct subgroups within Neisseria gonorrhoeae multi-antigen sequence type (NG-MAST) clusters. Epidemiol. Infect.136(3), 417–420 (2008).
   PubMedGoogle Scholar
• Bilek N, Martin IM, Bell G, Kinghorn GR, Ison CA, Spratt BG. Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts. J. Clin. Microbiol.45(11), 3564–3567 (2007).
   PubMedGoogle Scholar
• Golparian D, Hellmark B, Fredlund H, Unemo M. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex. Transm. Infect.86(6), 454–460 (2010).
   PubMed Web of Science ®Google Scholar
• Palmer HM, Young H, Graham C, Dave J. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect.84(4), 280–284 (2008).
   PubMed Web of Science ®Google Scholar
• Whiley DM, Goire N, Ray ES et al.Neisseria gonorrhoeae multi-antigen sequence typing using non-cultured clinical specimens. Sex. Transm. Infect.86(1), 51–55 (2010).
   PubMedGoogle Scholar
• Ison C. GC NAATs: is the time right? Sex. Transm. Infect.82(6), 515 (2006).
   PubMedGoogle Scholar
• Ota KV, Tamari IE, Smieja M et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex. Transm. Infect.85(3), 182–186 (2009).
   PubMed Web of Science ®Google Scholar
• Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex. Transm. Infect.35(7), 637–642 (2008).
   Google Scholar
• Alexander S. The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more? Sex. Transm. Infect.85(3), 159–160 (2009).
   PubMedGoogle Scholar
• Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J. Antimicrob. Chemother.60(3), 582–586 (2007).
   PubMed Web of Science ®Google Scholar
• Tapsall J, Read P, Carmody C et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J. Med. Microbiol.58(5), 683–687 (2009).
   PubMed Web of Science ®Google Scholar
• Tapsall JW. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sex. Transm. Infect.85(4), 256–258 (2009).
   PubMed Web of Science ®Google Scholar
• Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr. Opin. Infect. Dis.22(1), 87–91 (2009).
   PubMed Web of Science ®Google Scholar
• Chisholm SA, Alexander S, Desouza-Thomas L et al. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J. Antimicrob. Chemother. DOI: 10.1093/jac/dkr332 (2011) (Epub ahead of print).
   Google Scholar
• Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin. Med.73(4), 245–252 (1997).
   PubMedGoogle Scholar
• Bachmann LH, Desmond RA, Stephens J, Hughes A, Hook EW 3rd. Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhoea. J. Clin. Microbiol.40(10), 3596–35601 (2002).
   PubMed Web of Science ®Google Scholar
• Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J. Antimicrob. Chemother.65(10), 2141–2148 (2010).
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhoea? Detailed characterization of the first high-level ceftriaxone resistant strain. Antimicrob. Agents Chemother.55(7), 3538–3545 (2011).
   PubMed Web of Science ®Google Scholar